In this interview, Dr Usman Iqbal, head of Oncology Global Evidence &amp, Value Development at Sanofi, discusses market access in oncology and how to demonstrate value in this area in the US ...

The partners will use UNP's AI-based macrocycle discovery platform to develop synthetic peptide therapeutics for multiple ...

Please provide your email address to receive an email when new articles are posted on . More than half of study participants used personal care products that had formaldehyde or formaldehyde-releasing ...

Oncology products have been the biggest beneficiary of breakthrough status so far - of the 10 approvals to date, the majority have been for cancer drugs. And in terms of oncology branding, it ...

Lynozyflic is one of two bispecific antibodies Regeneron hopes will lift its oncology business. Meanwhile, IGM is the latest struggling biotech to agree to a buyout deal from Concentra.

Shanghai and San Francisco Bay Area-based HanchorBio has already taken HCB101, an engineered SIRPα-IgG4 Fc fusion protein, into phase 2 trials for solid tumors and hematologic malignancies including ...

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its ...

See the latest Roche Holding AG stock price (ROG:XSWX), related news, valuation, dividends and more to help you make your investing decisions.

Jerry A. Shields, MD, a world-renowned leader in ocular oncology, died June 22, according to a press release from Wills Eye Hospital. If you are an employed physician, regardless of setting, your ...

Roche is a Swiss biopharmaceutical and diagnostic company. The firm’s best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its ...